Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience


    loading  Checking for direct PDF access through Ovid

Abstract

The in vitro hollow fiber system model has been qualified by the European Medicines Agency as a methodology for use in support of selection and development of antituberculosis regimens. More data are expected to be generated in the future to further characterize its value.

    loading  Loading Related Articles